* Organogenesis Holdings Inc ORGO.OQ ORGO.O is expected
to show a fall in quarterly revenue when it reports results on
August 9.
* The Canton Massachusetts-based company is expected to
report a
5.2% decrease in revenue to $115.1 million from $121.4 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. The company's guidance on May 10 2023, for the
period ended June 30, was for revenue between $113.00 million
and $117.00 million.
* Refinitiv's mean analyst estimate for Organogenesis
Holdings
Inc is for earnings of 3 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
Organogenesis
Holdings Inc is $7.5, above its last closing price of $3.70.
This summary was machine generated August 8 at 01:57 GMT. All
figures in US dollars unless otherwise stated